Medical Marijuana Market Report 2026

The medical marijuana market size has grown exponentially in recent years. It will grow from $39.52 billion in 2025 to $48.13 billion in 2026 at a compound annual growth rate (CAGR) of 21.8%. The growth in the historic period can be attributed to legalization of medical cannabis in early markets, rising incidence of chronic pain and related disorders, traditional pharmaceutical limitations in managing symptoms, growing patient advocacy and awareness, increasing research on cannabis therapeutic potential.

The medical marijuana market size is expected to see exponential growth in the next few years. It will grow to $106.49 billion in 2030 at a compound annual growth rate (CAGR) of 22%. The growth in the forecast period can be attributed to expansion of cannabis legalization globally, advancements in cannabis extraction and formulation technologies, integration of digital health and telemedicine for cannabis delivery, rising investments in cannabis pharmaceutical R&D, increasing adoption of personalized medicine approaches. Major trends in the forecast period include increasing adoption of medical marijuana for pain management, expansion of cannabis-based pharmaceutical research, growth of e-commerce and online pharmacies for cannabis products, rising consumer awareness about alternative therapies, development of novel delivery methods for cannabis (oils, tinctures, edibles).

The rising prevalence of cancer is expected to drive growth in the medical marijuana market in the coming years. Cancer is a condition in which some of the body’s cells grow uncontrollably and spread to other regions. Medical marijuana is used to help manage cancer-related symptoms, including neuropathy, nausea, pain, vomiting, appetite loss, and weight loss. For example, in February 2024, according to the World Health Organization (WHO), a Switzerland-based specialized UN agency for international public health, over 35 million new cancer cases are projected by 2050, representing a 77% increase from the estimated 20 million cases in 2022. This rising prevalence of cancer is therefore expected to fuel demand for medical marijuana.

Key companies in the medical marijuana market are focusing on strategic investments in business expansion, such as establishing medical marijuana dispensaries to improve patient access and strengthen their presence in the evolving medical cannabis landscape. Medical marijuana dispensaries are authorized facilities where individuals with valid prescriptions or medical cards can legally purchase medicinal cannabis products. For instance, in July 2023, Botanical Sciences, a Georgia-based medical cannabis provider, opened a dispensary in Pooler near Savannah, with plans to expand further. Additional outlets are planned in Columbus and Evans, with further expansion aimed at Augusta, Chamblee, Marietta, and Stockbridge. Under Georgia regulations, medical marijuana operators are permitted to open up to six dispensaries each.

In February 2024, Curaleaf International, a UK-based biotechnology research company, acquired Can4Med LLC for an undisclosed amount. This acquisition aims to strengthen Curaleaf’s supply chain and improve access to high-quality medical cannabis products across multiple regions. Can4Med LLC is a Poland-based pharmaceutical manufacturing company.

Major companies operating in the medical marijuana market are Curaleaf Holdings Inc., Trulieve Cannabis Corp, Green Thumb Industries GTI Inc., Cresco Labs Inc., Tilray Inc, Aphria Inc., Canopy Growth Corporation, Jushi Holdings Inc., TerrAscend Corp, Aurora Cannabis Inc., HEXO Corp, MedMen Enterprises Inc., Organigram Holdings Inc., Charlotte's Web Holdings Inc., Vireo Health International Inc., Medical Marijuana Inc., VIVO Cannabis Inc., Valens GroWorks Corp, Green Relief Inc., Harborside Inc., MediPharm Labs Inc., Tikun Olam Cannbit Ltd., Emerald Health Therapeutics Inc., MedReleaf Corporation, GB Sciences Inc., CanniMed Therapeutics Inc., The Cronos Group Inc., Planet 13 Holdings Inc.

North America was the largest region in the medical marijuana market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global medical marijuana market during forecast period. The regions covered in the medical marijuana market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical marijuana market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the medical marijuana market by affecting the import and export of cannabis-derived products and cultivation equipment, resulting in increased costs for raw materials and finished products. The regulatory and trade restrictions particularly impact extract form and oils in North America and Europe, where import dependencies are higher. While tariffs may raise prices for some medical cannabis products, they also encourage local cultivation and production, potentially boosting domestic market growth and innovation in alternative delivery forms.

The medical marijuana market research report is one of a series of new reports that provides medical marijuana market statistics, including medical marijuana industry global market size, regional shares, competitors with a medical marijuana market share, detailed medical marijuana market segments, market trends and opportunities, and any further data you may need to thrive in the medical marijuana industry. This medical marijuana market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical marijuana refers to products derived from the cannabis sativa plant. It is used to address drug addiction or as an alternative to alcohol and other substances such as opiates and cocaine, as well as for managing pain, controlling nausea and vomiting, and providing pain relief.

The main types of medical marijuana products include dried flower and extract forms. Dried flower medical marijuana is used to treat certain mental and physical conditions or alleviate their symptoms. It consists of the smokable, trichome-rich portion of the cannabis plant, often incorporated into various cannabis products. The primary forms of medical marijuana include flower, concentrates, edibles, and other types. Medical marijuana is applied for pain management, Tourette syndrome, Alzheimer’s disease, migraines, depression and anxiety, multiple sclerosis, cancer, and other conditions, and is distributed through retail pharmacies, e-commerce platforms, and other channels.

The medical marijuana market consists of sales of cartridges, concentrates, flower and extracts. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.